Vertebral and knee surgery implant company Implanet established a German subsidiary.
Here are four things to know:
1. The German degenerative spine disease market is estimated at $300 million, with approximately 1,000 potential surgeon customers.
2. Implanet's new German branch will set up a mixed network of direct sales representatives and exclusive sales agents.
3. Implanet opened a United Kingdom sales branch in June.
4. According to Implanet CEO Ludovic Lastennet, the company's 2018-19 strategic plan involves promoting Implanet's product range directly in key European markets and preparing to integrate the products of its partner L&K Biomed.
More articles on devices:
Medtronic, Titan Spine, Wright Medical & more: 9 device company notes
US House repeals sales tax on medical devices: 4 details to know